可穿戴数字尿液传感器与患者报告结局整合用于前列腺切除术后尿失禁监测:一项前瞻性试点研究
这项前瞻性试点研究纳入2个学术中心60例接受机器人辅助根治性前列腺切除术(RARP)的局限性前列腺癌患者,评估可穿戴尿液传感器(智能尿垫)联合ICIQ-UI SF问卷的可行性、准确性和患者满意度。52例(87%随访)数据显示传感器事件与ICIQ-UI SF评分强相关(3个月时Spearman ρ=0.71,P<.001),使用数字干预者中位控尿恢复更快(4.2 vs 6.1个月,P=.03),患者满意度高(平均8.6/10),76%报告管理尿失禁的信心提升。
要点
- 可穿戴尿液传感器与ICIQ-UI SF评分强相关(3个月ρ=0.71,P<.001)
- 数字干预组中位控尿恢复更快(4.2 vs 6.1个月,P=.03)
- 患者满意度高(平均8.6/10),76%报告管理信心提升
核心结论
- 可穿戴尿液传感器联合患者报告结局和数字疗法,为RARP术后尿失禁管理提供有前景的个性化方法,可促进恢复和患者参与。
研究设计与样本
- 前瞻性试点研究,纳入2个学术中心60例因局限性前列腺癌接受RARP的患者。
- 参与者使用可穿戴尿液传感器(智能尿垫)监测漏尿量和频率,数据经智能手机应用传输。
- 术前及术后1、3、6、12个月完成ICIQ-UI SF问卷,传感器数据与问卷评分相关性分析并指导个性化干预。
主要发现
- 52例(87%随访)数据显示传感器事件与ICIQ-UI SF评分强相关(3个月Spearman ρ=0.71,P<.001)。
- 使用数字干预者中位控尿恢复更快(4.2 vs 6.1个月,P=.03)。
- 患者满意度高(平均8.6/10),76%报告管理尿失禁的信心提升。
临床怎么用
- 可将可穿戴尿液传感器与ICIQ-UI SF问卷结合用于RARP术后尿失禁的客观监测和随访。
- 传感器数据可指导盆底肌训练和行为治疗等数字化干预的个性化调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the feasibility, accuracy, and patient satisfaction of wearable urinary sensors used alongside the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) in managing urinary incontinence following robotic-assisted radical prostatectomy (RARP). METHODS: In this prospective study, 60 patients undergoing RARP for localized prostate cancer at 2 academic centers were enrolled. Participants used a wearable urinary sensor (smart pad) that monitored urine leakage volume and frequency via biosensors and transmitted data to a smartphone app. The ICIQ-UI SF was completed preoperatively and at 1, 3, 6, and 12 months postoperatively. Sensor data (episodes/day, average volume/episode) were correlated with questionnaire scores and informed tailored interventions, including pelvic floor muscle training and behavioral therapy delivered digitally. OUTCOMES MEASURED: RESULTS: Data from 52 patients (87% follow-up) showed a strong correlation between sensor events and ICIQ-UI SF scores (Spearman's ρ = 0.71 at 3 months, P <.001). Median continence recovery was faster in those using the digital intervention (4.2 vs 6.1 months, P = .03). Patient satisfaction was high (mean 8.6/10), with 76% reporting greater confidence in managing urinary incontinence. CONCLUSION: Wearable urinary sensors, combined with patient-reported outcomes and digital therapies, offer a promising, personalized approach to post-RARP incontinence management, enhancing both recovery and patient engagement.
引用
- Ahmad Z. Integration of Wearable Digital Urinary Sensors and Patient-reported Outcomes to Monitor Post-prostatectomy Incontinence: A Prospective Pilot Study. Urology. 2025. PMID: 40714011. doi:10.1016/j.urology.2025.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。